Aphelion Capital

Summary

In 2005 was created Aphelion Capital, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Mill Valley.

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Aphelion Capital, startups are often financed by Stanmore Medical Investments, TL Ventures, Research Corporation Technologies. The meaningful sponsors for the fund in investment in the same round are California Technology Ventures, River Cities Capital Funds, Research Corporation Technologies. In the next rounds fund is usually obtained by Ameritas Life Insurance, Tallwood Venture Capital, Synopsys.

The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019. Considering the real fund results, this VC is 9 percentage points less often commits exit comparing to other organizations. The top amount of exits for fund were in 2011. Comparing to the other companies, this Aphelion Capital performs on 7 percentage points less the average number of lead investments.

The fund was created by Ned Scheetz. We also calculated 2 valuable employees in our database.

Among the various public portfolio startups of the fund, we may underline CytoPherx, Providence Medical Technology, VasoNova We can highlight the next thriving fund investment areas, such as Software, Pharmaceutical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.